Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Control, a senior compliance officer


Articles
Mice on a Mission
December 2, 2012

To ensure the accuracy of scientific testing, protect the subjects to avoid data contamination.

Frozen Assets
November 2, 2012

Even when all is well at the facility, one must expect the worst while braving the elements.

Case Closed
October 2, 2012

Only the strong survive when it comes to pharmaceutical packaging and shipping.

Compliant or Contraband?
September 2, 2012

International trade can be great for business, but breaking border laws can put one in hot water.

Technology Fights Back
August 2, 2012

Meticulous system configuration can prevent machines from taking over.

A Lukewarm Reception
July 2, 2012

Careful attention to detail will help to prevent valuable assets from "melting" away.

A "Big E" on the Scoreboard
June 2, 2012

Even the slightest of errors in exponential calculations can cause the biggest of headaches.

All Eyes Alert
May 2, 2012

It's better to catch costly mistakes in the laboratory before they reach the accounting department.

Loose Lips Sink Ships
April 2, 2012

Failure to disclose info may work sometimes, but eventually every question will be answered.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here